Humacyte, Inc. (HUMA) Revenue History
Humacyte, Inc. (HUMA) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | $1.50M |
| 2021-12-31 | $1.26M |
| 2022-12-31 | $1.56M |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | $2.04M |
How HUMA compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| DYAI | Dyadic International Inc. | $3.09M |
| TXMD | TherapeuticsMD Inc. | $3.02M |
| VTGN | Vistagen Therapeutics Inc. | $1.27M |
| DMAC | DiaMedica Therapeutics Inc. | $500.00K |
| MNOV | MediciNova Inc. | $409.66K |
These are five companies in the same sector as HUMA with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Humacyte, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("HUMA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HUMA | $0.64 | -5.75% | 9.37M |
| 3 | ||||
| 4 | ||||
| 5 |